Oxford, UK – 17 May 2016: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, is pleased to announce that it has appointed Jefferies Hoare Govett as Sole Corporate Broker with immediate effect.
-Ends-